These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20183956)

  • 21. Cardiovascular risk management in community-dwelling elderly: opportunities for prevention.
    Ligthart SA; Richard E; van Gool WA; Moll van Charante EP
    Eur J Prev Cardiol; 2012 Dec; 19(6):1365-72. PubMed ID: 21930719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beyond risk factors: priorities and new challenges of cardiovascular prevention].
    Urbinati S; Giampaoli S
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):7S-14S. PubMed ID: 20879472
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of cardiovascular conditions in Australian general practice.
    Charles J; Britt H; Ng A
    Aust Fam Physician; 2005 Jun; 34(6):410-1. PubMed ID: 15931397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary Prevention of Cardiovascular Diseases and Application of Technology for Early Diagnosis.
    Karunathilake SP; Ganegoda GU
    Biomed Res Int; 2018; 2018():5767864. PubMed ID: 29854766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regular use of aspirin for cardiovascular disease prevention in Italy.
    Lugo A; Asciutto R; Bosetti C; Parazzini F; La Vecchia C; Gallus S
    Prev Med; 2014 Jun; 63():48-51. PubMed ID: 24613793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comments regarding "a systematic review of implementation of established recommended secondary prevention measures in PAOD".
    Lindahl AK
    Eur J Vasc Endovasc Surg; 2010 Jan; 39(1):87-8. PubMed ID: 19906546
    [No Abstract]   [Full Text] [Related]  

  • 27. Polypill strategy for primary prevention of cardiovascular disorders.
    Dabhadkar KC; Bellam N
    Drugs Today (Barc); 2013 May; 49(5):317-24. PubMed ID: 23724411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early sequential therapy].
    Med Monatsschr Pharm; 2005 Jul; 28(7):252-3. PubMed ID: 16038129
    [No Abstract]   [Full Text] [Related]  

  • 29. Preventing Cardiovascular Disease.
    DiNicolantonio JJ; O'Keefe JH
    Prog Cardiovasc Dis; 2016; 58(5):463. PubMed ID: 26875628
    [No Abstract]   [Full Text] [Related]  

  • 30. [Strategies for cardiovascular prevention in migrants].
    Perna GP; Carletti P; Deales A; Gabrielli D; Perna V
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):102S-105S. PubMed ID: 20879493
    [No Abstract]   [Full Text] [Related]  

  • 31. Aspirin underuse, non-compliance or cessation: definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease.
    Biondi-Zoccai G; Wu Y; Serrano CV; Frati G; Agostoni P; Abbate A
    Int J Cardiol; 2015 Mar; 182():148-54. PubMed ID: 25577751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?
    Ridker PM; Koenig W; Kastelein JJ; Mach F; Lüscher TF
    Eur Heart J; 2018 Dec; 39(46):4109-4111. PubMed ID: 30452612
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
    Lardizabal JA; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):87-103. PubMed ID: 21257102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editor's presentation.
    Piepoli MF
    Eur J Prev Cardiol; 2017 Jul; 24(10):1011-1013. PubMed ID: 28618853
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipid Lowering Is Beneficial for Secondary Prevention but Not Primary Prevention in Patients 75 Years and Older.
    Ebell MH
    Am Fam Physician; 2021 Jun; 103(11):695-696. PubMed ID: 34060787
    [No Abstract]   [Full Text] [Related]  

  • 36. [Recommendations for management of dyslipidemia in 2016 in Switzerland].
    Aubert CE; Gencer B; Rodondi N
    Rev Med Suisse; 2016 Mar; 12(508):430-4. PubMed ID: 27089598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of cardiovascular secondary prevention guidelines in clinical practice: a nationwide survey in Italy.
    Perrone-Filardi P; Poli A; Ambrosio G; Proto C; Chimini C; Chiariello M
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):149-53. PubMed ID: 20875948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary and secondary prevention of cardiovascular disease: is there a place for Internet-based interventions?
    Pietrzak E; Cotea C; Pullman S
    J Cardiopulm Rehabil Prev; 2014; 34(5):303-17. PubMed ID: 25079147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AAA- a further step towards a moratorium for aspirin in the primary prevention.
    Minar E
    Vasa; 2010 May; 39(2):119-122. PubMed ID: 20521434
    [No Abstract]   [Full Text] [Related]  

  • 40. Dissociating HDL cholesterol from cardiovascular risk.
    Hausenloy DJ; Opie L; Yellon DM
    Lancet; 2010 Jul; 376(9738):305-6. PubMed ID: 20655104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.